Giannoukakis Nick
University of Pittsburgh School of Medicine, Diabetes Institute, 3460 Fifth Avenue, Pittsburgh, PA 15213, USA.
Curr Opin Investig Drugs. 2005 Apr;6(4):410-8.
BioStratum is developing pyridoxamine (Pyridorin), an advanced glycation end-product (AGE) inhibitor, for the potential prevention of diabetic nephropathy. By January 2004, phase II trials had been completed.
生物地层公司正在研发吡哆胺(吡哆啉),一种晚期糖基化终产物(AGE)抑制剂,用于潜在预防糖尿病肾病。到2004年1月,二期试验已经完成。